cyclizine (Nastech)

N/A

Report date: 2025/03/19 20:00:56
NME

Base Information

Drug Namecyclizine (Nastech)
Drug Alias Namecyclizine
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistamine H1 receptor antagonists
TargetsHistamine H1 receptor
Therapy Area/IndicationsMotion Sickness
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAdhera Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAdhera Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsMotion Sickness

Other Information

ATC CodeN/A
Related LinksN/A